Opus Genetics
Price & Volume
Stats
See more52W Range | $0.65-$2.37 |
Market Cap | $129.6M |
Shares Short | 499,215 |
Financials
See moreRevenue (12 Mos) | $14.6M |
Revenue Growth (YoY) | -20.4% |
Gross Profit (12 Mos) | $7.3M |
Diluted EPS | -$1.86 |
News
See moreYahoo Finance • 7 days ago
Opus Genetics GAAP EPS of -$0.25 misses by $0.12, revenue of $3.08M in-line
Yahoo Finance • last month
Opus Genetics to Participate in Chardan's 9th Annual Genetic Medicines Conference
Yahoo Finance • 2 months ago
Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)
Yahoo Finance • 2 months ago
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Mr. George Magrath M.B.A., M.D., M.S. |
CFO | Mr. Robert E. Gagnon |
Address | 8 Davis Drive, Durham, NC, United States, 27709 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 18 |
